t r a c t a r t i c l e i n f o
OCT4 is a crucial transcription factor in the pluripotent stem cell gene regulatory network and an essential factor for pluripotent reprogramming. We engineered the previously reported HEL24.3 hiPSC to generate an OCT4 reporter cell line by knocking-in a T2A nuclear EmGFP reporter cassette before the OCT4 gene STOP codon sequence. To enhance targeted insertion, homologous recombination was stimulated using targeted cutting at the OCT4 STOP codon with CRISPR/SpCas9. This HEL24.3-OCT4-nEmGFP cell line faithfully reports endogenous OCT4 expression, serving as a useful tool to examine temporal changes in OCT4 expression in live cells during hiPSC culture, differentiation and somatic cell reprogramming.
© 
Resource utility
We engineered an OCT4-nEmGFP (nuclear Emerald Green Fluorescent Protein) reporter hiPSC that enables the examination of OCT4 expression in live hiPSC cells during stem cell maintenance, differentiation and reprogramming to pluripotency.
Resource details
OCT4 (also known as POU5F1 or Oct-3/4) is a transcription factor crucial for the formation, self-renewal and differentiation of pluripotent stem cells in the mammalian embryo. It is also a critical component of the transcription factors set used for reprogramming of somatic cells to pluripotent stage (Takahashi and Yamanaka, 2006) . We used the previously described human induced pluripotent stem cell line (hiPSC) HEL24.3 to generate an OCT4 reporter by knocking-in a T2A-NLS-EmGFP-P2A-Pac cassette at the endogenous OCT4 locus STOP codon sequence. Homologous recombination was stimulated using CRISPR/SpCas9 with a OCT4 STOP codon-targeted gRNA (Fig. 1A . nEmGFP reporter cassette targeting strategy: 2A self-cleaving sequences were used to generate a multicistronic reporter cassette that enables expression of nuclear localized EmGFP (NLS) and puromycin resistance gene Pac (Puro), allowing for positive selection of correctly targeted clones. Red and black arrowheads depict cutting gRNA binding site and screening PCR primers binding sites, respectively). The reporter cassette donor template was delivered by electroporation as a closed circular plasmid, together with SpCas9-expressing plasmid and a gRNA PCR transcriptional 
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Stem Cell Research j o u r n a l h o m e p a g e : w w w . e l s e v i e r . c o m / l o c a t e / s c r cassette. Clones resistant to puromycin were individually picked, expanded and screened for correct integration by PCR (Fig. 1B . Screening of reporter cassette recombination in the OCT4 locus by PCR using primers spanning 5′ and 3′ homology arms as depicted in Fig. 1A . Primers sequences detailed in Table 2 . Clones 1,2 and 3 are correctly targeted, while 4 and 5 are not targeted (W, water control; L, size ladder). Clone 1 was further single-cell sorted to ensure complete clonality of the reporter hiPSC. Heterozygous insertion of the reporter cassette was confirmed by PCR, while the non-targeted allele was intact (data not shown). HEL24.3-OCT4-nEmGFP reporter hiPSCs express bright nuclear EmGFP in live imaging (Fig. 1C . EmGFP fluorescence and overlaid brightfield (BF) image of a reporter colony by live microscopy). Characterization by immunocytochemistry showed overlapping of EmGFP signal with OCT4 (Fig. 1D ), SOX2 and NANOG staining in nuclei, with LIN28A in the cytoplasm, and with TRA-1-60 in the cell membrane Cloned from PX330 (Addgene Plasmid #42230) Deposited in Addgene (Fig. 1E) . Flow cytometry confirmed the expression of pluripotency markers TRA-1-60 and TRA-1-80 (Fig. 1F) . Karyotype was normal 46, XY (Fig. 1G ) and STR genotyping demonstrated its derivation from HEL24.3. (See Table 1 .) We tested the temporal expression of nEmGFP upon spontaneous differentiation in monolayer and in embryoid-body assay (Fig. 1H and  1I . Live microscopy of EmGFP and brightfield (BF) in monolayer (Fig.  1H ) and embryoid-bodies (Fig. 1I) ), resulting in a gradual decrease of EmGFP fluorescence in the differentiated cells. OCT4-nEmGFP reporter cells were capable of differentiating to the three germ layers by embryoid body assay, demonstrating their pluripotency (Fig. 1J) . AFP, endoderm marker alpha fetoprotein; SMA, mesoderm marker smooth muscle actin; TUJ1, neuroectoderm marker tubulin beta III). Directed differentiation of the reporter cells to definitive endoderm resulted in EmGFP fluorescence decrease in cells expressing endoderm markers FOXA2 and SOX17 (Fig. 1K) .
Fibroblast-like cells were derived from HEL24.3-OCT4-nEmGFP by prolonged culture of plated embryoid-bodies. We reprogrammed these cells back to pluripotency using replicative episomal plasmid technology and monitored daily the appearance of epithelial colonies and expression of EmGFP during the reprogramming process. First epithelial colonies were detected around day 13, already expressing nuclear EmGFP (Fig. 1L . Live microscopy for EmGFP and brightfield (BF) at different time points of the reprogramming process). From that timepoint onwards, reprogrammed cells formed colonies with the characteristic morphology of induced pluripotent stem cells that also expressed bright nEmGFP as a result of the endogenous OCT4 locus reactivation.
Materials and methods
hiPSC maintenance and differentiation were performed as described before (Balboa et al., 2015; Saarimäki-Vire et al., 2017; Balboa et al., 2017) .
Knock-in of reporter cassette in HEL24.3 OCT4 locus
Donor template pUC19-OCT4-T2A-NLS-EmGFP-P2A-Puro was cloned by PCR. EmGFP sequence was cloned from pcDNA™6.2/NEmGFP-DEST vector (V35620, Thermo Fisher). Homology arm lengths are 276 bp for 5′-homology-arm and 444 for 3′-homology-arm.
To stimulate homologous recombination of the donor template in the OCT4 STOP codon site, we utilized Streptococcus pyogenes Cas9 guide RNA-targeted endonuclease. To enable high expression in hiPSC, we cloned SpCas9 from pX330 plasmid (a gift from Feng Zhang, Addgene plasmid #42230) into a vector with a strong CAG promoter (CAG-Cas9, deposited in Addgene). We used Benchling (https:// benchling.com/academic) to design SpCas9 guide RNAs targeting OCT4 STOP codon sequence. Guide RNA transcriptional cassettes were assembled by PCR as described elsewhere (Balboa et al., 2015) .
2 μg pUC19-OCT4-T2A-NLS-EmGFP-P2A-Puro circular closed plasmid, 6 μg CAG-Cas9 plasmid and 0.5 μg of OCT4 stop codon SpCas9 gRNA PCR product were electroporated to two million HEL24.3 cells and plated onto Matrigel-coated plates on E8 medium containing 5 μM ROCK inhibitor (Y-27632 2HCl, Selleckchem). Electroporation, expansion, screening and single-cell sorting conditions are described elsewhere (Saarimäki-Vire et al., 2017) . Chromosomal G-banding karyotyping was done by Yhtyneet Medix Laboratories, Helsinki, Finland and STR analysis was performed by Genotyping Unit, Technology Centre, Institute for Molecular Medicine Finland, FIMM, Helsinki, Finland.
Immunocytochemistry and flow cytometry
Cells were fixed by incubation for 15 min with 4% PFA in PBS at room temperature. After two washes with 1× PBS, cells were permeabilized by incubation for 15 min with 0.5% Triton X-100 in 1× PBS. Cells were blocked by incubation with UltraV block (ThermoFisher) for 10 min. Staining with primary antibodies was performed in 0.1% Tween-PBS containing diluted antibodies at 4°C overnight. Cells were incubated with secondary antibodies diluted in 0.1% Tween-PBS after 3 washes with 1× PBS. List of antibodies used is detailed in Table 2 . Flow cytometry and analysis was performed as described elsewhere (Saarimäki-Vire et al., 2017) .
Embryoid body generation
To generate embryoid bodies structures, reporter hiPS cells were first dissociated into single cells by incubation for 10 min with 5 μM EDTA in 1× PBS and centrifuged at 200 rcf for 2 min. Cells were reaggregated overnight by resuspending them in E8 medium containing 10 μM ROCK inhibitor, seeding them at 10 6 cells/mL in an Ultra Low Attachment plate placed in an orbital rotation platform. Next day, ROCK inhibitor-containing E8 was removed, washed once with 1× PBS and Embryoid Body (EB) medium was added (DMEM/F12 with GlutaMAX (Life Technologies # 31331-028), 20% KnockOut Serum Replacement (Life technologies #10828-028), 0.0915 mM 2-mercaptoethanol (Life technologies #31350-010), 1× Non-Essential Amino Acids (NEAA) (Life technologies #11140-035)). EB medium was replaced every two or three days. After two weeks of culture in suspension, embryoid bodies were plated in Matrigel coated plates, let to attach and cultured in the plates for additional two weeks. Plated embryoid bodies were then fixed for immunocytochemistry or passaged several times to obtain fibroblast-like cells that were used for reprogramming experiments.
Reprogramming to pluripotency
Fibroblast-like cells derived from plated embryoid bodies were passaged 8 times. To reprogram these cells back to pluripotency, delivery of episomal reprogramming plasmids method was used. Briefly, 1 million fibroblast-like cells were electroporated using Neon system (ThermoFisher) with 6 μg episomal reprogramming plasmids pCXLEhOCT3/4-shp53, pCXLE-hSK and pCXLE-hUL (A gift from Shinya Yamanaka; Addgene plasmids #27077, #27078 and #27080). Electroporated cells were plated on Matrigel-coated plates and cultured in reprogramming media (1:1 mixture of hES and fibroblast media supplemented with 0.25 mM sodium butyrate) until colonies appeared.
